Herm Rosenman Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 4 months ago
Herm Rosenman has an estimated net worth of at least $26.3 million*, as of Oct. 29, 2025. They own 20,441 shares of NTRA stock. They have sold 186,823 shares of NTRA stock since 2021, for an estimated $13.0 million.
Herm Rosenman $NTRA SEC Form 4 Insider Trading
Herm Rosenman has filed a total of 10 insider trades in $NTRA since 2021. Their most recent trade was a sale of 14,372 shares, made on Dec 12, 2025. Their largest trade was a sale of 57,954 shares, made on Feb 16, 2024. We estimate that they now own 20,441 shares of $NTRA, worth an estimated $13.2 million.
Insider Trading at $NTRA
There have been a total of 1095 insider trades reported at $NTRA since 2021, with 375,220 shares purchased and 4.6 million shares sold. The most active insider traders in $NTRA stock have been Steven Leonard Chapman, Michael Burkes Brophy, and Daniel Rabinowitz. The most recent trade was a sale of 850 shares reported by Solomon Moshkevich (PRESIDENT, CLINICALDIAGNOSTICS), made on Feb 02, 2026.
History of Insider Stock Trades by Herm Rosenman
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
NTRA
|
Sale | 14,372 | Dec 12, 2025 | Dec. 16, 2025, 10:05 p.m. |
|
NTRA
|
Sale | 21,910 | Dec 12, 2025 | Dec. 16, 2025, 10:05 p.m. |
|
NTRA
|
Sale | 11,987 | Dec 12, 2025 | Dec. 16, 2025, 10:05 p.m. |
|
NTRA
|
Sale | 150 | Dec 12, 2025 | Dec. 16, 2025, 10:05 p.m. |
|
NTRA
|
Sale | 35,947 | Feb 16, 2024 | Feb. 16, 2024, 10:45 p.m. |
|
NTRA
|
Sale | 57,954 | Feb 16, 2024 | Feb. 16, 2024, 10:45 p.m. |
DMTK
|
Purchase | 20,000 | May 09, 2022 | May 11, 2022, 8:02 p.m. |
|
NTRA
|
Sale | 2,832 | Nov 08, 2021 | Nov. 8, 2021, 8 p.m. |
|
NTRA
|
Sale | 400 | Nov 08, 2021 | Nov. 8, 2021, 8 p.m. |
|
NTRA
|
Sale | 39,171 | Nov 08, 2021 | Nov. 8, 2021, 8 p.m. |
|
NTRA
|
Sale | 2,100 | Nov 08, 2021 | Nov. 8, 2021, 8 p.m. |
$NTRA Executives and Stock Owners with Insider Trades
-
Steven Leonard Chapman, CEO AND PRESIDENT
-
Michael Burkes Brophy, CHIEF FINANCIAL OFFICER
-
Daniel Rabinowitz, SEC. AND CHIEF LEGAL OFFICER
-
Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS
-
Matthew Rabinowitz, EXECUTIVE CHAIRMAN
-
John Fesko, PRESIDENT, CHIEF BUS. OFFICER
-
Robert Alan Schueren, CHIEF OPERATING OFFICER
-
Daniel Rabinowitz, CHIEF LEGAL OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.